New Ultrasound Memory Study
Join our groundbreaking research on ultrasound technology for memory enhancement. Help pioneer the future of cognitive wellness.
Learn About Study HereJoin our groundbreaking research on ultrasound technology for memory enhancement. Help pioneer the future of cognitive wellness.
Learn About Study HereUltraDAO builds on a decade of ultrasound applications in neuromodulation. Current focus: neurodegenerative diseases (Alzheimer's, dementia), consciousness studies (Orch-OR theory), and nervous system modulation.
Ultrasound DAO builds upon a decade of hands-on experience in ultrasound technology applications for human physiological stimulation, encompassing the nervous system, brain, Vagus nerve, and parasympathetic function.
Our research is particularly influenced by the groundbreaking work of Dr. Stuart Hameroff and Roger Penrose on Microtubules and consciousness (Orch-OR Theory), opening new frontiers in understanding human consciousness and neurological function.
Primary focus on combating Alzheimer's and Dementia through targeted ultrasound applications to neuronal microtubule networks.
Exploring the deeper aspects of human consciousness through ultrasound interaction with neural microtubules.
Investigating ultrasound applications for vagus nerve stimulation and parasympathetic function optimization.
Decade of experience in ultrasound technology applications for physiological stimulation.
Focused research on neurodegenerative diseases and consciousness through ultrasound application.
Expanding research through community participation and IP-NFT framework implementation.
UltraDAO's research isn't a cost centre that runs until the grant dries up — it's a loop. Each validated frequency becomes an asset that funds the next study, and the people who took the risk to prove it out share in the upside.
The DAO treasury pays for a clinical trial. UXDT holders vote on which study runs next, so the research agenda is set by the community.
A specific therapeutic frequency profile is proven out — the same rigorous work described in the tracks above.
The validated frequency becomes an IP-NFT. Trial participants and early adopters get ownership — the risk-takers finally share the reward.
Every IP-NFT carries a 7.5% royalty back to the treasury, which funds the next trial. The loop closes and turns again.
Fund → validate → own → royalty → fund. Governed by UXDT (voting stock); treasury held in KAS.
Join our community-driven research initiative and help shape the future of neurological treatment.